Editor's letter

Welcome to the latest issue of the Medical Technology magazine 

In this month's edition, we explore how a high profile partnership between continuous glucose monitoring (CGM) giant Dexom and Finnish wearable company ŌURA Health is revolutionising the diabetes technology sector. Dexcom’s partnership with ŌURA is a key milestone in diabetes management as it sees two different markets amalgamating.

Next, we feature an interview with ALAFIA about their new supercomputer Aivas. The interactive high-performance personal supercomputer is designed for the deployment of AI software applications in healthcare and has already seen early adoption by researchers from the Stanford Medical School Department of Neurology and Neurological Sciences.

We also venture into the digital frontier of the metaverse. As virtual worlds expand and evolve, healthcare giant Pfizer is investing in the metaverse through a virtual lung oncology diagnostic lab created by VR and AR developer Cassette Group. 

Catherine Longworth, editor